85 related articles for article (PubMed ID: 18068976)
21. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
[TBL] [Abstract][Full Text] [Related]
22. The effect of a hydroxamic acid-containing polymer on active matrix metalloproteinases.
Skarja GA; Brown AL; Ho RK; May MH; Sefton MV
Biomaterials; 2009 Apr; 30(10):1890-7. PubMed ID: 19147221
[TBL] [Abstract][Full Text] [Related]
23. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions.
Ullmann U; Gilles C; De Rycke M; Van de Velde H; Sermon K; Liebaers I
Mol Hum Reprod; 2008 Mar; 14(3):169-79. PubMed ID: 18263607
[TBL] [Abstract][Full Text] [Related]
24. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
[TBL] [Abstract][Full Text] [Related]
25. N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines.
Amorelli B; Yang C; Rempel B; Withers SG; Knapp S
Bioorg Med Chem Lett; 2008 May; 18(9):2944-7. PubMed ID: 18406613
[TBL] [Abstract][Full Text] [Related]
26. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
27. Synthetic active site-directed inhibitors of metzincins: achievement and perspectives.
Yiotakis A; Dive V
Mol Aspects Med; 2008 Oct; 29(5):329-38. PubMed ID: 18657570
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of polyhydroxy piperidines and their analogues: a novel approach towards selective inhibitors of alpha-glucosidase.
Pandey G; Bharadwaj KC; Khan MI; Shashidhara KS; Puranik VG
Org Biomol Chem; 2008 Jul; 6(14):2587-95. PubMed ID: 18600280
[TBL] [Abstract][Full Text] [Related]
29. Computer modeling and nanosecond simulation of the enzyme-substrate complex of the common lymphoblastic leukemia antigen (neprilysin) indicates shared residues at the primary specificity pocket (S1') with matrix metalloproteases.
Manzetti S
J Mol Model; 2003 Oct; 9(5):348-54. PubMed ID: 14517614
[TBL] [Abstract][Full Text] [Related]
30. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F
J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605
[TBL] [Abstract][Full Text] [Related]
31. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
[TBL] [Abstract][Full Text] [Related]
32. Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors.
Tuccinardi T; Nuti E; Ortore G; Rossello A; Avramova SI; Martinelli A
Bioorg Med Chem; 2008 Aug; 16(16):7749-58. PubMed ID: 18640045
[TBL] [Abstract][Full Text] [Related]
33. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.
Grandas OH; Mountain DJ; Kirkpatrick SS; Rudrapatna VS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
J Surg Res; 2008 Jul; 148(1):94-9. PubMed ID: 18570937
[TBL] [Abstract][Full Text] [Related]
34. Analysis of alpha2-adrenergic receptors and effect of brimonidine on matrix metalloproteinases and their inhibitors in human ciliary body.
Ooi YH; Oh DJ; Rhee DJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4237-43. PubMed ID: 19324857
[TBL] [Abstract][Full Text] [Related]
35. Recent advancement of piperidine moiety in treatment of cancer- A review.
Goel P; Alam O; Naim MJ; Nawaz F; Iqbal M; Alam MI
Eur J Med Chem; 2018 Sep; 157():480-502. PubMed ID: 30114660
[TBL] [Abstract][Full Text] [Related]
36. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
37. [Structure and function of matrix metalloproteinases].
Olszyński K; Zimowska M
Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468
[TBL] [Abstract][Full Text] [Related]
38. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
[TBL] [Abstract][Full Text] [Related]
40. Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines.
Hubbard RD; Dickerson SH; Emerson HK; Griffin RJ; Reno MJ; Hornberger KR; Rusnak DW; Wood ER; Uehling DE; Waterson AG
Bioorg Med Chem Lett; 2008 Nov; 18(21):5738-40. PubMed ID: 18842405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
